Longwood Capital Partners

Latest statistics and disclosures from Acuta Capital Partners's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Acuta Capital Partners

Acuta Capital Partners holds 43 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Replimune Group Call Option (REPL) 42.9 $267M NEW 151k 1766.00
 View chart
Sarepta Therapeutics Call Option (SRPT) 35.6 $221M NEW 16k 13783.00
 View chart
Taysha Gene Therapies Com Shs (TSHA) 1.9 $12M NEW 3.8M 3.16
 View chart
Apellis Pharmaceuticals (APLS) 1.5 $9.3M -17% 245k 38.04
 View chart
Aadi Bioscience (AADI) 1.4 $9.0M 1.8M 4.84
 View chart
Praxis Precision Medicines I 1.2 $7.7M +5% 4.5M 1.71
 View chart
Rayzebio (RYZB) 1.2 $7.6M NEW 345k 22.20
 View chart
Rocket Pharmaceuticals (RCKT) 1.2 $7.4M +18% 362k 20.49
 View chart
Ventyx Biosciences (VTYX) 1.1 $7.1M +39% 205k 34.73
 View chart
Disc Medicine (IRON) 1.0 $6.5M 138k 46.98
 View chart
Kura Oncology (KURA) 1.0 $6.4M 702k 9.12
 View chart
Cymabay Therapeutics (CBAY) 1.0 $6.2M -2% 418k 14.91
 View chart
Vaxcyte (PCVX) 1.0 $6.2M 121k 50.98
 View chart
Immunovant (IMVT) 0.8 $5.0M -8% 129k 38.39
 View chart
Syndax Pharmaceuticals (SNDX) 0.7 $4.3M 297k 14.52
 View chart
Hillevax (HLVX) 0.6 $3.6M +328% 270k 13.45
 View chart
Alkermes SHS (ALKS) 0.6 $3.5M +183% 127k 28.01
 View chart
Miragen Therapeutics (VRDN) 0.6 $3.4M 224k 15.34
 View chart
Celldex Therapeutics Com New (CLDX) 0.5 $3.4M 122k 27.52
 View chart
Crinetics Pharmaceuticals In (CRNX) 0.4 $2.8M NEW 94k 29.74
 View chart
Terns Pharmaceuticals (TERN) 0.4 $2.8M -42% 555k 5.03
 View chart
Eyepoint Pharmaceuticals Com New (EYPT) 0.4 $2.4M -21% 300k 7.99
 View chart
Ikena Oncology (IKNA) 0.4 $2.4M 551k 4.33
 View chart
Centessa Pharmaceuticals Sponsored Ads (CNTA) 0.3 $2.1M NEW 323k 6.47
 View chart
Olema Pharmaceuticals (OLMA) 0.3 $1.9M +44% 153k 12.35
 View chart
Verastem Com New (VSTM) 0.3 $1.9M -23% 230k 8.13
 View chart
Enliven Therapeutics (ELVN) 0.2 $1.4M 104k 13.66
 View chart
Dyne Therapeutics (DYN) 0.2 $1.3M +100% 147k 8.96
 View chart
Kronos Bio (KRON) 0.2 $934k +128% 719k 1.30
 View chart
Aclaris Therapeutics (ACRS) 0.1 $834k 122k 6.85
 View chart
Brainstorm Cell Therapeutics Com New Put Option (BCLI) 0.1 $825k NEW 2.5k 330.00
 View chart
Biomea Fusion (BMEA) 0.1 $550k 40k 13.76
 View chart
89bio (ETNB) 0.1 $522k NEW 34k 15.44
 View chart
Ionis Pharmaceuticals (IONS) 0.1 $513k NEW 11k 45.36
 View chart
Leap Therapeutics Com New (LPTX) 0.1 $489k NEW 354k 1.38
 View chart
Rezolute Com New (RZLT) 0.1 $409k -16% 310k 1.32
 View chart
Cellectar Biosciences Com New (CLRB) 0.1 $320k NEW 121k 2.64
 View chart
Structure Therapeutics Sponsored Ads (GPCR) 0.0 $252k NEW 5.0k 50.42
 View chart
An2 Therapeutics (ANTX) 0.0 $214k NEW 13k 16.08
 View chart
Marinus Pharmeceuticals Com New (MRNS) 0.0 $157k NEW 20k 8.05
 View chart
Mersana Therapeutics (MRSN) 0.0 $127k NEW 100k 1.27
 View chart
Glycomimetics (GLYC) 0.0 $41k NEW 28k 1.50
 View chart
Nuvation Bio *w Exp 07/07/2027 (NUVB.WS) 0.0 $9.1k 91k 0.10
 View chart

Past Filings by Acuta Capital Partners

SEC 13F filings are viewable for Acuta Capital Partners going back to 2014

View all past filings